Blog Posts in May, 2013
-
Ranbaxy Resumes Sales After Pharmaceutical Recall
Posted By Kaiser Gornick LLPIndian drug maker Ranbaxy Laboratories recently resumed supplying its cholesterol lowering drugs to the U.S. market. The company was shut down by the FDA in January after glass particles were found in some lots of its drugs. Last January, the FDA and the Department of Justice filed a consent decree of permanent injunction against the company so as to bar it from operating in the U.S. until it ...Continue Reading -
Compounding Pharmacies Forced To Recall Tainted Drugs
Posted By Kaiser Gornick LLPSeveral compounding pharmacies across the country were recently forced to recall their products after federal inspectors found sanitation issues at their facilities. Compounding pharmacies mix sterile specialty drugs for patients who had specific prescriptions. Last year, filthy conditions at a New England compounding pharmacy resulted in a multistate fungal meningitis outbreak that killed 53 ...Continue Reading
Page
1 of 1